These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 140145)

  • 1. An unexpected high frequency of trisomic fetuses in 229 pregnancies monitored for advanced maternal age.
    Sachs ES; Jahoda MG; Niermeijer MF; Galjaard H
    Hum Genet; 1977 Apr; 36(1):43-6. PubMed ID: 140145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features of abnormal chromosome karyotypes in twin pregnancies complicated with structural abnormalities].
    Zhong SL; Fang Q; Chen BJ; Han ZY; Luo YM; Chen JS; Xie YJ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):649-54. PubMed ID: 22176987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter study of fetal chromosomal abnormalities in Chinese women of advanced maternal age.
    Zhu Y; Lu S; Bian X; Wang H; Zhu B; Wang H; Xu Z; Xu L; Yan W; Zeng Y; Chen Z; Tang S; Shen G; Miao Z
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):379-84. PubMed ID: 27343319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatally detectable markers for the diagnosis of autosomally trisomic fetuses in at-risk pregnancies.
    Salihu HM; Boos R; Schmidt W
    Am J Perinatol; 1997 May; 14(5):257-61. PubMed ID: 9259939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prenatal diagnosis in pregnancies at advanced maternal age (author's transl)].
    Wirtz A; Haas B; Krauss C; Stengel-Rutkowski S; Murken JD
    Geburtshilfe Frauenheilkd; 1978 Jun; 38(6):422-30. PubMed ID: 149691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome studies of embryos from induced abortions in pregnant women age 35 and over.
    Tsuji K; Nakano R
    Obstet Gynecol; 1978 Nov; 52(5):542-4. PubMed ID: 152877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
    Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.
    Nicolaides KH; Brizot ML; Snijders RJ
    Br J Obstet Gynaecol; 1994 Sep; 101(9):782-6. PubMed ID: 7947527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome variation in perinatal mortality: a survey of 500 cases.
    Angell RR; Sandison A; Bain AD
    J Med Genet; 1984 Feb; 21(1):39-44. PubMed ID: 6229635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
    Ashwood ER; Cheng E; Luthy DA
    Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic evidence for enhanced selective miscarriage of trisomy 21 pregnancies with advancing maternal age.
    Kratzer PG; Golbus MS; Schonberg SA; Heilbron DC; Taylor RN
    Am J Med Genet; 1992 Nov; 44(5):657-63. PubMed ID: 1481829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of advanced maternal age on prenatal diagnosis of trisomies 13, 18 and 21.
    Drugan A; Yaron Y; Zamir R; Ebrahim SA; Johnson MP; Evans MI
    Fetal Diagn Ther; 1999; 14(3):181-4. PubMed ID: 10364671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate patterns in trisomic fetuses.
    Kariniemi V; Aula P
    J Perinat Med; 1982; 10(5):242-6. PubMed ID: 6217310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
    Kagan KO; Cicero S; Staboulidou I; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
    Sullivan A; Giudice T; Vavelidis F; Thiagarajah S
    Am J Obstet Gynecol; 1999 Aug; 181(2):260-5. PubMed ID: 10454666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
    Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.
    Nicolaides KH
    Am J Obstet Gynecol; 2004 Jul; 191(1):45-67. PubMed ID: 15295343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.